prospective comparison neuropsychologic performance children leukemia cranial irradiation late neuropsychologic toxicities CNS prophylaxis childhood acute lymphoblastic leukemia ALL longitudinal assessments groups patients repeated courses moderate-dose intravenous IV intrathecal methotrexate IT MTX cranial irradiation MTX group IT MTX Gy cranial irradiation group IT MTX Gy cranial irradiation group patients free CNS leukemia diagnosis continuous complete remission years median years CNS prophylaxis analysis serial intelligence quotient IQ achievement neuropsychologic studies significant influence age CNS prophylaxis CNS group neuropsychologic outcome measure changes IQ test versions patient age significant declines Verbal Performance Full Scale IQs CNS treatment groups comparisons group declines individual children children significant deterioration equal points uncorrected IQ values study period Female sex risk deterioration Verbal IQ unable risk factors declines intellect achievement inability predict individual patients risk significant neuropsychologic toxicities basis age diagnosis specific method CNS prophylaxis etiologic factors basis changes ecologic factors chemotherapy continuation phase treatment 